FRONTAL FIBROSING ALOPECIA
Clinical trials for FRONTAL FIBROSING ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new FRONTAL FIBROSING ALOPECIA trials appear
Sign up with your email to follow new studies for FRONTAL FIBROSING ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which drug wins? new study takes on frontal fibrosing alopecia
Disease control Not yet recruitingThis study compares two medicines, hydroxychloroquine and methotrexate, to see which works better for frontal fibrosing alopecia (FFA), a scarring hair loss that mainly affects women. About 50 adults with FFA who choose one of these treatments will be followed for up to 48 weeks.…
Matched conditions: FRONTAL FIBROSING ALOPECIA
Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Hope for hair loss: new pill targets scarring alopecia
Disease control Not yet recruitingThis study tests a daily pill called deucravacitinib in 20 adults with two types of scarring hair loss (CCCA and FFA). The goal is to see if the drug can reduce inflammation and scarring on the scalp over 48 weeks. Participants take the medication for the entire study period, so …
Matched conditions: FRONTAL FIBROSING ALOPECIA
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Apr 24, 2026 16:20 UTC
-
New laser zaps away facial bumps in hair loss condition
Symptom relief Not yet recruitingThis study will test if a special laser (1726nm) can safely shrink or remove small bumps that appear on the face in people with frontal fibrosing alopecia, a type of hair loss. Ten adults with these facial bumps will receive the laser treatment. Doctors will measure changes in bu…
Matched conditions: FRONTAL FIBROSING ALOPECIA
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated May 11, 2026 20:52 UTC